Normobaric oxygen may correct chronic cerebral ischemia‐mediated EEG anomalies

AIMS: To explore the safety and efficacy of normobaric oxygen (NBO) on correcting chronic cerebral ischemia (CCI) and related EEG anomalies. METHODS: This prospective randomized trial (NCT03745092) enrolled 50 cases of CCI patients, which were divided into NBO (8 L/min of oxygen supplement) group an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Jia‐Yue, Liu, Yu, Rajah, Gary‐B., Chen, Zhi‐Ying, Zhang, Shi‐Yong, Ding, Yu‐Chuan, Ji, Xun‐Ming, Meng, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446210/
https://www.ncbi.nlm.nih.gov/pubmed/34242498
http://dx.doi.org/10.1111/cns.13703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446210/
https://www.ncbi.nlm.nih.gov/pubmed/34242498
http://dx.doi.org/10.1111/cns.13703

Ejemplares similares